Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Ana Rendón"'
1
Prevalence of Dystonia in Antioquia, Colombia
Autor: Juan Marcos Solano Atehortua, Omar Buritica Henao, Ana Rendón Bañol, Sandra Patricia Isaza Jaramillo
Publikováno v: Neuroepidemiology. 46(2)
Background: There are few published epidemiological studies concerning dystonia. Its true prevalence has been difficult to establish. There is no data published in Latin America on this matter. Methods: In this study the prevalence of dystonias in th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01b1375f5f807e76624f2763349438b0
https://pubmed.ncbi.nlm.nih.gov/26820666
Zobrazit plný text záznamu
2
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir
Autor: Ivana Maida, Pablo Rivas, Sonia Rodriguez-Novoa, Pablo Barreiro, Francisco J. Blanco, Vincent Soriano, Ana Barrios, Juan González-Lahoz, Teresa García-Benayas, Ana Rendón
Publikováno v: AIDS Research and Human Retroviruses. 22:333-337
The combination of didanosine (ddI) and tenofovir (TDF) has potential advantages, but because of several pitfalls (unexpected decreases in CD4+ T cells, increased risk of pancreatitis) its use has been questioned. Since anecdotal cases of transient i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de7b9637866e73075ff2b964aa1734c
https://doi.org/10.1089/aid.2006.22.333
Zobrazit plný text záznamu
3
Clinical benefit of interventions driven by therapeutic drug monitoring
Autor: Juan González-Lahoz, Marina Núñez, Ana Rendón, D González de Requena, Inmaculada Jiménez-Nácher, Vincent Soriano
Publikováno v: HIV Medicine. 6:360-365
Background Adequate plasma concentrations of antiretroviral drugs are key to achieving and maintaining long-term suppression of HIV replication. Multiple factors may influence drug levels, causing increases or reductions that may, respectively, resul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f2582245176d8ec454baa172762f84
https://doi.org/10.1111/j.1468-1293.2005.00321.x
Zobrazit plný text záznamu
4
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
Autor: Belén Ramos, Echevarría S, Antonio Ocampo, Piedad Arazo, Celia Miralles, Vincent Soriano, Javier García-Samaniego, Josep M. Guardiola, Miguel Angel Berdún, Pablo Barreiro, M. Romero, Iria Santos, Pablo Labarga, Elena Losada, Marina Núñez, Ana Rendón
Publikováno v: Journal of viral hepatitis. 14(6)
The response to hepatitis C virus (HCV) therapy seems to be lower in HCV/HIV-coinfected patients than in HCV-monoinfected individuals. Given that most pivotal trials conducted in coinfected patients have used the combination of pegylated interferon (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec2d4b8af664a2254f24fddd8f633223
https://pubmed.ncbi.nlm.nih.gov/17501758
Zobrazit plný text záznamu
6
Pharmacogenetics in HIV therapy
Autor: Sonia, Rodríguez-Nóvoa, Pablo, Barreiro, Inmaculada, Jiménez-Nacher, Ana, Rendón, Vincent, Soriano
Publikováno v: AIDS reviews. 7(2)
Administration of standard doses of most antiretroviral drugs results in significant variations in plasma drug concentrations among different individuals, as well as different rates of drug-associated toxicity. The reasons for the large interindividu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b60d110547636050a22c7005f574ac6
https://pubmed.ncbi.nlm.nih.gov/16092504
Zobrazit plný text záznamu
7
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C--T polymorphism at the multidrug resistance gene 1
Autor: Ana Rendón, Angélica Corral, Juan González-Lahoz, Sonia Rodríguez Novoa, Inmaculada Jiménez-Nácher, Pablo Barreiro, Ana Barrios, Vincent Soriano
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 42(2)
The 3435C-->T polymorphism at the multidrug resistance gene 1 (MDR1) was examined in 74 patients with human immunodeficiency virus who initiated atazanavir therapy. The MDR1 genotype distribution at position 3435 was 28% CC, 45% CT, and 27% TT. Plasm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0b66a20ac7d69f624b6fedb80d63e0
https://pubmed.ncbi.nlm.nih.gov/16355344
Zobrazit plný text záznamu
9
Combinations of nucleoside/nucleotide analogues for HIV therapy
Autor: Pablo, Barreiro, Teresa, García-Benayas, Ana, Rendón, Sonia, Rodríguez-Novoa, Vincent, Soriano
Publikováno v: AIDS reviews. 6(4)
Nucleoside and nucleotide analogues are essential for the design of effective antiretroviral regimens. There are currently many options for the selection of such drug backbones, although not all combinations will display optimal results. The concomit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b90b1f9d2861ff9e20bb9ec7fc5c9f3
https://pubmed.ncbi.nlm.nih.gov/15700622
Zobrazit plný text záznamu
10
Influence of 516GT polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects
Autor: Sonia Rodriguez-Novoa, Pablo Barreiro, Ana Rendón, Juan González-Lahoz, Vincent Soriano, Inmaculada Jiménez-Nácher
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 40(9)
We examined 516G>T polymorphisms at the gene encoding the cytochrome P450 in 100 human immunodeficiency virus-positive subjects who were receiving efavirenz (EFV). Elevated plasma EFV concentrations were found in 40% of subjects with the polymorphic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9d1afc8f3fb92323d7600c418d756d
https://pubmed.ncbi.nlm.nih.gov/15825040
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje